Metraipolis › archive › dc_2a3f89084e6f

The impact of anti-HBc positivity on clinical outcomes and treatment response in immune thrombocytopenia — Europe PMC PMID:40788479

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40788479
DOI
10.1007/s00508-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-10T17:45:52.700Z
SHA-256 of the archived text
e2af112031f61c71b14df3ba0c0c339e049f211b09489bc4b5c8a3bede6b79c2
Stable URL of this page
https://metraipolis.com/documento/dc_2a3f89084e6f

How to cite

The impact of anti-HBc positivity on clinical outcomes and treatment response in immune thrombocytopenia — Europe PMC PMID:40788479 — Europe PMC (en), https://europepmc.org/article/MED/40788479 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a3f89084e6f (Metraipolis archive dc_2a3f89084e6f, sha256 e2af112031f61c71b14df3ba0c0c339e049f211b09489bc4b5c8a3bede6b79c2)
BibTeX
@misc{dc2a3f89084e6f,
  title = {The impact of anti-HBc positivity on clinical outcomes and treatment response in immune thrombocytopenia — Europe PMC PMID:40788479},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40788479},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a3f89084e6f; sha256 e2af112031f61c71b14df3ba0c0c339e049f211b09489bc4b5c8a3bede6b79c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40788479. Agents can read the archived copy with the MCP tool read_document.